Clinical Trial Update: Pharmacokinetics, Efficacy and Safety of an Octreotide Implant in Patients With Carcinoid Syndrome [Phase 1, Phase 2]

View source ↗

Summary

The document reports pharmacokinetics, efficacy and safety results from phase 1/2 studies of an octreotide implant in patients with carcinoid syndrome. The tria…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carcinoid Syndrome

Drugs mentioned

• Octreotide Implant (octreotide)

Snippet

Sponsor: Endo Pharmaceuticals | Conditions: Carcinoid Syndrome | Phase 1, Phase 2 | Status: TERMINATED